Moderna, Inc. logo

MRNAModerna, Inc.

MRNA Stock Price, Valuation & Chart | Moderna, Inc.

Compare

MRNA Historical price chart

MRNA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization61.21B
PE Ratio-18.93
EPS-8.15
Trading Volume25.69M
Today's High/Low154.7/138.09
Dividend Yield0.00
52 Week High/Low176.66/22.28
Shares Outstanding396.79M
MRNA Financial Statement
MRNA Analyst ratings
MRNA Analysis & performance metrics

MRNA Company profile

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases,…

MRNA Management team

Management
Stephen Hoge M.D.
President
Jerh Collins Ph.D.
Chief Technical Operations & Quality Officer
Shannon Thyme Klinger J.D.
Chief Legal Officer & Corporate Secretary
Lavina Talukdar CFA
Senior Vice President & Head of Investor Relations
Melanie Ivarsson M.B.A., Ph.D.
Chief Development Officer
Charbel Haber M.P.H., Ph.D.
Senior Vice President & Head of Global Regulatory Science
James M. MockCFO
Chief Financial Officer
Dave Johnson
Chief Data & AI Officer
Total 8 executives

MRNA Frequently asked questions

What is Moderna, Inc. (MRNA) Stock Price?

Current stock price of Moderna, Inc. (MRNA) stock is $154.27. The stock price is +9.93% higher in the session. The intraday range can be seen from this page. Volume of Moderna, Inc. (MRNA) stock is 25.69M.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Moderna, Inc. (MRNA) stock price going up or down today?

The stock price of Moderna, Inc. (MRNA) can change with earnings, company news, and overall market sentiment. Moderna, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Moderna, Inc. stock expensive at its current price?

Whether Moderna, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MRNA on this page is -18.93. EPS on this page is -8.15. Compare those figures with peers and growth expectations before deciding if the current Moderna, Inc. price is justified.

How has the stock price of Moderna, Inc. (MRNA) performed historically?

Historical performance for Moderna, Inc. (MRNA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MRNA reacted to past earnings and market events.

Should I buy Moderna, Inc. (MRNA) stock, at this price?

Buying Moderna, Inc. (MRNA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.